/PRNewswire/ Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued an.
/PRNewswire/ Analysts at TMR estimate the HER2 breast cancer test market to expand at a CAGR of 6.5% over the forecast period from 2021 to 2031. Clinically,.
/PRNewswire/ A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled.